US 8628782
Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction
granted A61KA61K2039/5258A61K2039/545
Quick answer
US patent 8628782 (Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/5258, A61K2039/545, A61K2039/55505, A61K2039/55561